NORAHOME: Home-based multimodal monitoring and care for people with minor stroke and TIA
Official title: NORA-HOME. Efficiency And Safety An Ambulatory Multimodal Monitoring Model In Patients With Minor Stroke And Transient Ischemic Attacks
Run by Hospital Universitari Vall d'Hebron Research Institute · NCT07500116 · Data updated 2026-11-12
This project tests whether giving adults with minor stroke or TIA a multimodal home-hospitalization program can be as safe, reduce complications, and be more efficient than standard hospital care.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Hospital Universitari Vall d'Hebron Research Institute Academic / other |
| Locations | 1 site (Barcelona) |
| Status | Recruiting |
| Started | January 29, 2025 |
| Main results expected | June 29, 2027 |
| Study ends | June 29, 2027 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT07500116 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 who present to the ED with TIA (full recovery <24 hours) or minor stroke (NIHSS ≤ 5), are clinically stable, have a smartphone and caregiver support, and can give informed consent.
✕Probably not a fit
Patients needing urgent reperfusion or revascularization for severe stenosis/occlusion, those with major pre-existing neurological or psychiatric conditions, terminal illness, or barriers to follow-up (for example language or lack of caregiver/smartphone) are unlikely to benefit from home hospitalization.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
NORAHOME compares a multimodal home-hospitalization pathway to standard clinical practice for adults who present to the emergency department with minor stroke or TIA. Eligible patients who are clinically stable, have family or caregiver support and a smartphone receive coordinated remote monitoring, home nursing/clinical visits, and early initiation of secondary prevention instead of routine inpatient admission. The main goals are to lower early stroke recurrence and hospital readmissions while maintaining safety, and to measure patient-reported outcomes and efficiency. The program is delivered from Vall d'Hebron and participation is voluntary with informed consent.
Why it matters
Potential benefit: If successful, patients could avoid routine hospital admission while receiving close monitoring and faster preventive care at home, potentially lowering complications and improving experience.
How similar studies have gone: Hospital-at-home and outpatient TIA clinic models have shown feasibility and some benefits in other settings, but multimodal home hospitalization specifically for TIA/minor stroke remains relatively limited and needs formal validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients presenting to the Emergency Department with symptoms of TIA (complete recovery of neurological deficits within \<24 hours) or minor stroke (NIHSS ≤ 5) * Age \>18 years. * Availability of a smartphone for the patient or caregiver. * Family support and/or formal caregiver. * Clinical stability during the last 12 hours in the Emergency Department. * Signed informed consent by the patient and/or family member or legal representative. Exclusion Criteria: * Severe stenosis or symptomatic arterial occlusion requiring admission for potential reperfusion and/or arterial revascularization treatments. * Patients with pre-existing neurological or psychiatric conditions that may interfere with or complicate follow-up and evaluations. * Clinical (terminal condition) or social (language barrier) impossibility to complete follow-up assessments.
Where it's running
-
Vall Hebron University Hospital
Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Marian Muchada Lopez, MD, PHD
- Email: mangeles.muchada@vallhebron.cat
- Phone: +34 934893000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stroke care during COVID-19 waves: patterns in admissions and treatments
This study tests how stroke and TIA care patterns changed during the later waves of the COVID-19 pandemic by analyzing hospital data on admissions, stays, thrombolysis, and thrombectomy.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Self-Supervised Constraint-Induced Movement Therapy for Stroke Recovery
This study tests a partly self-guided therapy program to help adults recover the use of their weaker arm after stroke, aiming to require less time with a therapist.
-
Cerebral Small Vessel Disease Progression by Stroke Type
This study tests whether CSVD progresses differently if a patient has a concurrent ischemic stroke, using MRI and blood biomarkers in adults.
-
Pemafibrate for Symptomatic ICAS
This study tests whether pemafibrate can help prevent worsening of intracranial artery narrowing in people with symptomatic ICAS and high triglycerides after a stroke or TIA.
-
Using IMPROVE to guide carotid revascularisation decisions
This trial tests whether using the IMPROVE MRI-based score to select patients for carotid revascularisation is as good as standard care based mainly on stenosis degree, among people who have had a recent stroke or TIA due to carotid disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.